Max Salfinger, MD, FAAM, FIDSA

Max Salfinger
Lab Director, Mycobacteriology & Pharmacokinetics
Advanced Diagnostic Laboratories
Department of Medicine
Division of Pathology
Max Salfinger, MD,FIDSA,FAAM, is a mycobacteriology expert at National Jewish Health. Dr. Salfinger is in Advanced Diagnostic Laboratories.

image descriptionPrograms & Services
Research AreasResearch Areas
  • Rapid diagnosis of tuberculosis and nontuberculous mycobacteria (NTM)

Special Interests

Dr. Salfinger oversees the clinical laboratory aspect as well as research and development for tuberculosis, nontuberculous mycobacteria (NTM) and pharmacokinetics. He has a keen interest in providing more rapid diagnosis for drug-resistant tuberculosis and NTM disease, and aiding the healthcare providers in selecting the most efficacious drug regimen. 


University of Basel, MD
University of Basel School of Medicine,
Swiss Medical State Board,

Awards & Recognition

2012: Fellow, Infectious Diseases Society of America
2005: Gardner Middlebrook Award, Becton Dickinson
2003: Honorary Professor, Kazakh National Medical University, Ministry of Health of the Republic of Kazakhstan, Almaty, Kazakhstan
2002: Fellow, American Academy of Microbiology
1996: Commissioner’s Recognition Award, New York State Department of Health
1996: Keynote address at the Student Poster Awards Day, School of Public Health, University at Albany, Albany, NY
1984: Prize of the Swiss Society for Internal Medicine
1970: European Philips Contest for Young Scientists and Inventors
1970 : Swiss Youth Research Prize

Board Certification

Laboratory Director Certificate of Qualification, Mycobacteriology [New York State]
Physician [Switzerland]
Laboratory Director FAMH, Medical Microbiology [Switzerland]

Professional Memberships

Swiss Medical Association (FMH)
American Society for Microbiology
International Union Against Tuberculosis and Lung Disease
Swiss Society for Pneumology
American Thoracic Society
National Tuberculosis Controllers Association
Infectious Disease Society of America
Association of Public Health Laboratories
Florida Public Health Association
Florida Medical Association


Somoskovi A; Parsons L; Gutierrez C; Lee E; Salfinger M: Line probe and automated real-time PCR TB assays warrant adherence to strict quality assurance measures [Letter to the Editor] Int. J. Tuberc. Lung Dis. 16:705-706 (2012)

Somoskovi A, Dormandy J, Mitsani D, Rivenburg J, Salfinger M: Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin J. Clin. Microbiol. 44:4459-4463(2006)

Parsons LM, Brosch R, Cole ST, Somoskovi A, Loder A, Bretzel G, van Soolingen D, Hale YM, Salfinger M: Rapid and simple approach for identification of Mycobacterium tuberculosis complex isolates by PCR-based genomic deletion analysis
J. Clin. Microbiol. 40:2339-2345(2002)

Debrunner M, Salfinger M, Brändli O, von Graevenitz A: Epidemiology and clinical significance of nontuberculous mycobacteria in HIV-negative patients in Switzerland Clin. Infect. Dis. 15:330-345(1992)

Salfinger M, Heifets L: Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radio-metric method Antimicrob. Agents Chemother. 32:1002-1004(1988)

Teaching & Professional Positions

2007–present: Affiliate Professor, Department of Global Health, College of Public Health, University of South Florida, Tampa, FL
2006–2012: Chief, Bureau of Laboratories, Florida Department of Health, Tallahassee, FL
2008–2011: Adjunct Prof., Div. of Pulmonary, Critical Care & Sleep Medicine, College of Medicine, University of Florida, Gainesville, FL
2006–2009: Adjunct Professor of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY
2000–2006: Professor of Biomedical Sciences, School of Public Health, University at Albany, Albany, NY
2003–2007: Adjunct Professor of Medicine, Albany Medical College, Albany, NY
1996–2002: Adjunct Associate Professor of Medicine, Albany Medical College, Albany, NY
1992–2006: Director, Clinical Mycobacteriology Laboratory (Division of Infectious Disease) & Section Head, Mycobacteriology (Clinical Laboratory Evaluation Program) New York State Department of Health, WADSWORTH CENTER, Albany, NY
1984–1992 : Teaching Fellow, University of Zürich, Zürich, Department of Medical Microbiology
1981–1992: Head, Tuberculosis Laboratory, Department of Medical Microbiology, University of Zürich, Zürich, Switzerland
1978–1981: Fellow, Microbiology Laboratory, University Hospital Basel, Basel, Switzerland

Conflicts of Interest

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Ask a Question through Patient Portal

Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account

Contact Information

  • Office: 303.398.1384
  • Fax: 303.398.1953
  • Alternate: 303.398.1339
  • Email:



  • National Jewish Health Main Campus
    1400 Jackson St.
    Denver, CO 80206

Patient Ratings

The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes.

Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.